◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › L › LH

Laboratory Corporation of America Holdings (LH) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Health Care Services · DATA UPDATED 2026-09-19

Laboratory Corporation of America Holdings (LH) operates in the Health Care Services industry and is headquartered in Burlington, United States with about 71,000 employees. Its market capitalization is roughly $26 billion. In the fiscal year ended 2025-12-31, LH reported $14.0B in revenue and $876M in net income.

Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments.

Interactive charts & full statements → Open the LH valuation workbench →

LH Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$14.3B	$14.0B	$13.0B	$12.2B	$11.9B	$13.1B	$14.0B	$11.6B	$11.3B	$10.4B	$9.6B	$8.7B	$6.0B	$5.8B	$5.7B	$5.5B	$5.0B	$4.7B	$4.5B	$4.1B	$3.6B
Gross Profit	$4.0B	$3.7B	$3.6B	$3.4B	$3.7B	$5.0B	$5.0B	$3.3B	$3.2B	$3.5B	$3.2B	$2.9B	$2.2B	$2.2B	$2.2B	$2.3B	$2.1B	$2.0B	$1.9B	$1.7B	$1.5B
Gross Margin %	27.9%	26.8%	27.9%	27.7%	31.3%	38.0%	35.4%	28.1%	28.0%	33.2%	33.0%	33.5%	36.6%	38.3%	39.7%	41.0%	41.9%	42.0%	41.6%	41.6%	42.6%
Operating Income (EBIT)	$1.6B	$1.5B	$1.1B	$726M	$1.4B	$3.0B	$2.4B	$1.3B	$1.3B	$1.4B	$1.3B	$1.0B	$910M	$991M	$1.0B	$948M	$979M	$936M	$843M	$777M	$697M
Operating Margin %	11.3%	10.9%	8.3%	6.0%	12.1%	23.2%	17.5%	11.5%	11.7%	13.1%	13.6%	11.6%	15.1%	17.1%	18.1%	17.1%	19.6%	19.9%	18.7%	19.1%	19.4%
Net Income	$1.0B	$876M	$746M	$418M	$1.3B	$2.4B	$1.6B	$824M	$884M	$1.3B	$732M	$437M	$511M	$574M	$583M	$520M	$558M	$543M	$464M	$477M	$432M
Net Margin %	7.0%	6.3%	5.7%	3.4%	10.8%	18.1%	11.1%	7.1%	7.8%	12.2%	7.6%	5.0%	8.5%	9.9%	10.3%	9.4%	11.2%	11.6%	10.3%	11.7%	12.0%
EBITDA	$2.2B	$2.0B	$1.8B	$1.3B	$2.0B	$3.7B	$3.3B	$2.1B	$2.1B	$1.8B	$1.8B	$1.6B	$1.2B	$1.2B	$1.3B	$1.2B	$1.2B	$1.1B	$1.0B	$990M	$853M
Earnings Per Share (EPS)	$12.09	$10.46	$8.84	$4.77	$13.96	$24.38	$15.88	$8.35	$8.61	$12.21	$7.02	$4.34	$5.92	$6.25	$5.99	$5.11	$5.30	$4.98	$4.10	$3.93	$3.24
Shares Outstanding (M)	82M	84M	84M	88M	92M	98M	98M	99M	103M	104M	104M	101M	86M	92M	97M	102M	105M	109M	113M	121M	133M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

LH Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$3.7B	$3.5B	$3.5B	$3.6B	$3.5B	$3.3B	$3.3B	$3.3B
Gross Profit	$1.1B	$938M	$921M	$1.0B	$1.0B	$948M	$896M	$904M
Gross Margin %	29.8%	26.5%	26.2%	28.8%	29.7%	28.3%	26.9%	27.6%
Operating Income (EBIT)	$452M	$387M	$382M	$397M	$394M	$326M	$216M	$254M
Operating Margin %	12.1%	10.9%	10.9%	11.1%	11.2%	9.8%	6.5%	7.7%
Net Income	$299M	$278M	$165M	$261M	$238M	$213M	$143M	$169M
Net Margin %	8.0%	7.8%	4.7%	7.3%	6.7%	6.4%	4.3%	5.2%
EBITDA	$621M	$548M	$419M	$564M	$532M	$498M	$418M	$422M
Earnings Per Share (EPS)	$3.64	$3.35	$1.98	$3.12	$2.83	$2.52	$1.70	$2.01
Shares Outstanding (M)	82M	83M	83M	84M	84M	84M	84M	84M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

LH Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$1.6B	$1.6B	$1.6B	$1.3B	$2.0B	$3.1B	$2.1B	$1.4B	$1.3B	$1.5B	$1.2B	$982M	$739M	$819M	$841M	$856M	$884M	$862M	$781M	$710M	$632M
Capital Expenditures (CapEx)	$483M	$434M	$490M	$454M	$482M	$460M	$382M	$400M	$380M	$315M	$279M	$256M	$204M	$202M	$176M	$146M	$126M	$115M	$157M	$143M	$116M
Free Cash Flow (FCF)	$1.2B	$1.2B	$1.1B	$874M	$1.5B	$2.6B	$1.8B	$1.0B	$926M	$1.1B	$897M	$727M	$536M	$616M	$665M	$710M	$757M	$748M	$624M	$566M	$516M
FCF Margin %	8.1%	8.6%	8.4%	7.2%	12.4%	20.2%	12.5%	9.0%	8.2%	11.0%	9.3%	8.4%	8.9%	10.6%	11.7%	12.8%	15.1%	15.9%	13.9%	13.9%	14.4%
Dividends Paid	$239M	$241M	$243M	$254M	$195M	$1.0B	$152M	$2.4B	$467M	$3.3B	$140M	$0M	$1M	$1.1B	$1.3B	$1.4B	$551M	$593M	$371M	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

LH Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$446M	$192M	$614M	$387M	$621M	$18M	$777M	$277M
Capital Expenditures (CapEx)	$132M	$121M	$124M	$107M	$78M	$126M	$112M	$116M
Free Cash Flow (FCF)	$314M	$70M	$490M	$280M	$543M	($108M)	$665M	$162M
FCF Margin %	8.4%	2.0%	14.0%	7.9%	15.4%	-3.2%	20.0%	4.9%
Dividends Paid	$59M	$61M	$59M	$60M	$60M	$62M	$60M	$60M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

LH Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$18.5B	$18.4B	$18.4B	$16.7B	$20.2B	$20.4B	$20.1B	$18.0B	$16.2B	$16.6B	$14.2B	$14.3B	$7.3B	$7.0B	$6.8B	$6.2B	$6.2B	$4.9B	$4.7B	$4.4B	$4.0B
Cash & Cash Equivalents	$142M	$532M	$1.5B	$537M	$321M	$1.5B	$1.3B	$338M	$427M	$317M	$434M	$716M	$580M	$404M	$467M	$159M	$231M	$148M	$220M	$56M	$52M
Total Liabilities	$9.9B	$9.8B	$10.3B	$8.8B	$10.0B	$10.1B	$10.6B	$10.5B	$9.2B	$9.8B	$8.7B	$9.1B	$4.5B	$4.5B	$4.1B	$3.6B	$3.6B	$2.6B	$2.9B	$2.6B	$2.0B
Total Debt (Short + Long-Term)	$6.0B	$5.8B	$6.5B	$5.2B	$5.5B	$5.6B	$6.0B	$6.4B	$6.1B	$6.8B	$5.8B	$6.4B	$3.0B	$3.0B	$2.7B	$4.3B	$2.5B	$2.4B	$1.7B	$1.7B	$1.2B
Total Shareholders' Equity	$8.6B	$8.6B	$8.1B	$7.9B	$10.1B	$10.3B	$9.4B	$7.6B	$7.0B	$6.8B	$5.5B	$4.9B	$2.8B	$2.5B	$2.7B	$2.5B	$2.6B	$2.2B	$1.7B	$1.7B	$2.0B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive LH viewer.

LH Metric Deep Dives

Other Companies in Health Care Services

CVS · CVS Health — $114 billion
CI · Cigna — $73 billion
DGX · Quest Diagnostics — $27 billion
DVA · DaVita — $12 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← LGWU All “L” companies LHA →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.